T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes

被引：13

作者：

Park, Hye Sun ^{[1
,2
]}

McIntosh, Lacey ^{[3
,4
]}

Braschi-Amirfarzan, Marta ^{[3
,4
]}

Shinagare, Atul B. ^{[3
,4
]}

Krajewski, Katherine M. ^{[3
,4
]}

机构：

[1] Univ Ulsan, Coll Med, Dept Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA

来源：

KOREAN JOURNAL OF RADIOLOGY | 2017年 / 18卷 / 01期

关键词：

T-cell lymphoma; Non-Hodgkin lymphoma; CT; MRI; PET-CT; NATURAL KILLER/T-CELL; LYMPHOBLASTIC LYMPHOMA; MYCOSIS-FUNGOIDES; PROGNOSTIC-FACTORS; UNITED-STATES; F-18-FDG PET/CT; SEZARY-SYNDROME; TRANSFORMATION; FEATURES; TRANSPLANTATION;

D O I：

10.3348/kjr.2017.18.1.71

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

T-cell non-Hodgkin Lymphomas (NHLs) are biologically diverse, uncommon malignancies characterized by a spectrum of imaging findings according to subtype. The purpose of this review is to describe the common subtypes of T-cell NHL, highlight important differences between cutaneous, various peripheral and precursor subtypes, and summarize imaging features and the role of imaging in the management of this diverse set of diseases.

引用

页码：71 / 83

页数：13

共 50 条

[21] Increased radiosensitivity in a child with T-cell non-Hodgkin's lymphoma
AttardMontalto, SP
Saha, V
Kingston, J
Plowman, N
Taylor, M
Arlett, C
Bridges, B
Eden, O
MEDICAL AND PEDIATRIC ONCOLOGY, 1996, 27 (06): : 565 - 570
[22] Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma -: The MD Anderson Cancer Center experience
Escalón, MP
Liu, NS
Yang, Y
Hess, M
Smith, TL
Dang, NH
CANCER, 2005, 103 (10) : 2091 - 2098
[23] Incursions Into the Epidemiological Spectrum and Treatment Strategy for Aggressive Non-Hodgkin Lymphomas
Musteata, Vasile
Nitrean, Adrian
Urescu, Dumitrita
Mindruta-Stratan, Rodica
Musteata, Larisa
Covalschi, Elena
Sghibneva-Bobeico, Nina
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S416 - S417
[24] Follicular non-Hodgkin lymphomas and minimal residual disease.
Bruno, S
MEDICINA-BUENOS AIRES, 2000, 60 : 77 - 82
[25] Co-existent de novo Myelodysplastic Syndrome and T-cell Non-Hodgkin Lymphoma: a Common Origin or Not?
Huang, H. -H
Zhu, J. -Y
Han, J. -Y
Shen, L. -J
Xu, L.
Chen, X. -L
Zheng, L. -Y
Chen, F. -Y
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (01) : 270 - 276
[26] Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
Hartmann, Sylvia
Scharf, Sonja
Steiner, Yvonne
Loth, Andreas G.
Donnadieu, Emmanuel
Flinner, Nadine
Poeschel, Viola
Angel, Stephanie
Bewarder, Moritz
Bein, Julia
Brunnberg, Uta
Bozzato, Alessandro
Schick, Bernhard
Stilgenbauer, Stephan
Bohle, Rainer M.
Thurner, Lorenz
Hansmann, Martin-Leo
CANCERS, 2021, 13 (20)
[27] Extranodal Non-Hodgkin Lymphomas: The Impact of Different Variables on the Disease
Yogi, Veenita
Singh, Om Prakash
Redhu, Pallavi
Francis, Bibin
MIDDLE EAST JOURNAL OF CANCER, 2019, 10 (04) : 324 - 332
[28] CAR T-Cell Therapy for Relapsed/Refractory Non-Hodgkin's Lymphoma: A Comprehensive Review
St-Pierre, Frederique
Gordon, Leo, I
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 309 - 318
[29] Interim Report of A Phase 2 Clinical Trial of Lenalidomide for T-Cell Non-Hodgkin Lymphoma
Dueck, Greg
Chua, Neil
Prasad, Angeli
Finch, Daygen
Stewart, Doug
White, Darrell
van der Jagt, Richard
Johnston, James
Belch, Andrew
Reiman, Tony
CANCER, 2010, 116 (19) : 4541 - 4548
[30] Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma
Ryan, Russell James Hubbard
Wilcox, Ryan Alan
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (04) : 553 - +

← 1 2 3 4 5 →